Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Tecan Group Ltd    TECN   CH0012100191

TECAN GROUP LTD

(TECN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Tecan : Automated metabolic analysis in photodynamic tumor therapy

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 09:25am EST

By Siegfried Sasshofer

Photodynamic Therapy (PDT) is being increasingly recognized as having potential for the treatment of tumors, especially dermatological. But using conventional manual methods of recording the metabolic processes that occur as a result of adding the photosensitizer to target cells has major limitations.

For a start, monitoring response processes can take up to three days, which leads to night gaps that can introduce an element of error into capturing data. Also the number of parameters is limited by the fact that it's only possible to work manually with 96-well plates.

Dr. Kristjan Plaetzer at the University of Salzburg, Austria set out to see whether there were benefits to automating the entire PDT process, from seeding cells to monitoring response processes. He used a Tecan Spark® 10M reader along with a standard plate wash. The results proved conclusively that automation increases accuracy, maximizes the number of parameters that can be tested in a single experiment and minimizes costs by saving time and money.

Dr Plaetzer's presentation of his impressive findings is essential viewing if you're the head of an academic laboratory, interested in cancer therapies or long-term research on metabolic processes. But it's also required viewing for anyone who is researching into the benefits of automation.

WATCH THE VIDEO

Disclaimer

Tecan Group AG published this content on 12 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 February 2019 14:24:37 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TECAN GROUP LTD
09:13aTECAN : Synthetic biology has real-world applications
PU
02/19TECAN : Metagenomics may provide answers to irritable bowels, asthma attacks and..
PU
02/14TECAN : Five essential software questions to ask before buying a liquid handling..
PU
02/12TECAN : Automated metabolic analysis in photodynamic tumor therapy
PU
02/07TECAN : The new standards for phenotypic screening
PU
02/05TECAN : launches NGS DreamPrep™ delivering unprecedented speed and accurac..
PU
01/30AUTOMATING YOUR ANATOMICAL PATHOLOGY : how to get there faster
PU
01/24TECAN : Molecular diagnostics – a closer look at sample to answer
PU
01/17TECAN : Seeking powerful analytics to improve lab procurement? Here's what to lo..
PU
01/15TECAN : Six benefits to implementing LC-MS sample prep automation
PU
More news
Financials (CHF)
Sales 2018 591 M
EBIT 2018 87,4 M
Net income 2018 72,5 M
Finance 2018 286 M
Yield 2018 0,93%
P/E ratio 2018 37,32
P/E ratio 2019 32,86
EV / Sales 2018 3,99x
EV / Sales 2019 3,60x
Capitalization 2 648 M
Chart TECAN GROUP LTD
Duration : Period :
Tecan Group Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TECAN GROUP LTD
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 239  CHF
Spread / Average Target 6,3%
EPS Revisions
Managers
NameTitle
David Roy Martyr Chief Executive Officer
Lukas Braunschweiler Chairman
Ulrich Kanter EVP, Head-Development & Operations Division
Rudolf Eugster Chief Financial Officer
Heinrich Fischer Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
TECAN GROUP LTD17.92%2 642
CANON INC11.17%38 817
FUJIFILM HOLDINGS CORP19.43%23 390
RICOH CO LTD8.12%7 612
XEROX CORP55.11%7 356
SEIKO EPSON CORPORATION11.41%6 061